Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
DIS$119.00+0.05(+0.04%)Disney's Pixar names Jonathan Garson president as Jim Morris steps back7:45:05 PM ETNVDA$200.66-5.90(-2.86%)Here's What $10,000 Invested in SpaceX and Nvidia Could Be Worth by 20307:29:00 PM ETSNAP$5.23-0.37(-6.61%)Snap Q3: The Potential Is There - The Conviction Isn't7:28:29 PM ETIBM$254.32+4.28(+1.71%)Did IBM Just Tell the Truth About AI?7:26:39 PM ETARR$12.67+0.53(+4.37%)Polen 5Perspectives Large Growth Composite Q3 2026 Portfolio Performance And Attribution7:25:00 PM ETAMZN$265.80-0.23(-0.09%)UPDATE 4-Markets cheer Democratic win, betting divided Washington means fewer policy shocks7:20:31 PM ETC$124.58+1.89(+1.54%)UPDATE 1-Citi employee killed in shooting at Florida office, suspect dead7:10:16 PM ETAVGO$325.49-6.60(-1.99%)Steve Weiss Says the Midterms Just Put a Lid on AI Spending. Here's Who Could Get Hurt7:09:14 PM ETXOM$169.14-8.36(-4.71%)Polypropylene Market Size to Reach 139.2 Million Tons by 2032 as Asia-Pacific Packaging and Homopolymer Demand Surge, Reports Mordor Intelligence7:00:00 PM ETGOOG$290.10+2.80(+0.97%)Why Alphabet Stock Popped on Wednesday6:53:01 PM ETAAPL$351.05+1.54(+0.44%)Qualcomm: Apple's Exit Is Accelerating, But So Is Its Replacement6:45:31 PM ETQCOM$161.57-11.62(-6.71%)Qualcomm Stock Down 8% Post Earnings Beat: The Market Lost Its Mind6:15:22 PM ETINTC$58.09-2.41(-3.98%)Intel: The Foundry Trap Is Getting Worse5:48:47 PM ETCVX$216.69-0.27(-0.12%)Joe Terranova Says “Inflation Lost” on Election Night. What That Means for Energy Stocks5:07:08 PM ETQCOM$161.57-11.62(-6.71%)Qualcomm's stock falls as twin forces pressure sales5:03:00 PM ETORCL$124.09+0.36(+0.29%)Wednesday's Final Takeaways: CVS Splitting in Two, ORCL Scraps Tencent Deal5:00:33 PM ETORCL$124.09+0.36(+0.29%)Stock Market Today, Nov. 4: Oracle Falls on Canceled $7 Billion Tencent Chip-Leasing Deal5:00:02 PM ETADI$404.20-15.60(-3.72%)Analog Devices (ADI) Stock Sinks As Market Gains: Here's Why5:00:01 PM ETSPCX$134.65-1.27(-0.93%)How Much Is SpaceX's AI Business Really Worth? Here's the Math.4:59:00 PM ETAMZN$265.80-0.23(-0.09%)Stock Market Today, Nov. 4: Amazon Jumps 6% From New Perspective on AWS Growth and AI Strategy Following Election Results4:53:28 PM ETMETA$631.72+1.72(+0.27%)Meta isn't naming its AI models after fruit anymore4:53:20 PM ETAAPL$351.05+1.54(+0.44%)Apple (AAPL)) Price Forecast: Record High Follows Dramatic Reversal4:52:47 PM ETQCOM$161.57-11.62(-6.71%)Qualcomm's Phone Chip Sales Drop 26%: Rapid Earnings Reaction4:50:19 PM ETMCD$279.00-1.22(-0.44%)Stock Market Today, Nov. 4: Dow Surges 3% in Biggest Post-Midterm Rally in 44 Years4:50:01 PM ET

SION · NASDAQ

Sionna Therapeutics, Inc.

$3.73 +0.08 (+2.19%)

Company overview

Sionna Therapeutics, Inc. is a biopharmaceutical company developing a treatment paradigm for cystic fibrosis patients by creating medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Market cap
$168M
Employees
41
Headquarters
Waltham, MA
Website
sionnatx.com
CEO
Michael Cloonan
Listed
February 7, 2025
P/E
-1.93
Dividend yield
0.00%

Company financials

Revenue
$0.00
Gross profit
-$453,000
Operating income
-$98.9M
EBITDA
-$88.6M
Net income
-$85.6M
EPS
-$1.93
Total assets
$305M
Total debt
$8.4M
Earnings yield
-51.74%

Price chart

1.4915.3829.2643.1457.03
SION 1D NASDAQ O3.76H3.87L3.56C3.65-0.08 (-2.14%)Vol908.78K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
View
Ticker Type Headline Source Published
SIONSionna Therapeutics, Inc. Press release Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences GlobeNewswire
SIONSionna Therapeutics, Inc. Stock news Sionna Therapeutics, Inc. (SION) Loses 37.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Zacks Investment Research
SIONSionna Therapeutics, Inc. Stock news Sionna Therapeutics, Inc. (NASDAQ:SION) Stock Has Average Target Price of $42.33 According to Brokerages Defense World
SIONSionna Therapeutics, Inc. Legal Oct 01, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sionna Therapeutics, Inc. - SION Pomerantz LLP is investigating claims on behalf of investors of Sionna Therapeutics, Inc. PR Newswire
SIONSionna Therapeutics, Inc. Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sionna Therapeutics, Inc. - SION GlobeNewswire
SIONSionna Therapeutics, Inc. Stock news SION to Cut Workforce by Nearly Half After CF Study Failure, Stock Down Zacks Investment Research
SIONSionna Therapeutics, Inc. Stock news Brokerages Set Sionna Therapeutics, Inc. (NASDAQ:SION) Price Target at $42.22 Defense World
SIONSionna Therapeutics, Inc. Stock news Sionna Therapeutics, Inc. (SION) Discusses Post-Hoc Analysis of PreciSION CF Trial and Advancement of Dual Combination Program Transcript Seeking Alpha
SIONSionna Therapeutics, Inc. Press release Sionna Therapeutics Announces Plans to Advance SION-451 + SION-2222 Dual Combination into Phase 2a Proof-of-Concept Trial GlobeNewswire
SIONSionna Therapeutics, Inc. Legal SIONNA THERAPEUTICS INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Sionna Therapeutics Inc on Behalf of Sionna Therapeutics Stockholders and Encourages Investors to Contact the Firm GlobeNewswire
SIONSionna Therapeutics, Inc. Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sionna Therapeutics, Inc. - SION GlobeNewswire
SIONSionna Therapeutics, Inc. Legal SION INVESTIGATION: Investigation Launched into Sionna Therapeutics, Inc., Robbins Geller Rudman & Dowd LLP Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm GlobeNewswire
SIONSionna Therapeutics, Inc. Legal INVESTIGATION ALERT: Investigation Launched into Sionna Therapeutics, Inc., Robbins Geller Rudman & Dowd LLP Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm - SION PRNewsWire
SIONSionna Therapeutics, Inc. Legal Securities Fraud Investigation Into Sionna Therapeutics, Inc. (SION) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm GlobeNewswire
SIONSionna Therapeutics, Inc. Legal INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sionna Therapeutics, Inc. - SION GlobeNewswire
SIONSionna Therapeutics, Inc. Legal Robbins LLP Reminds Investors it is Investigating Sionna Therapeutics for Potential Securities Violations GlobeNewswire
SIONSionna Therapeutics, Inc. Legal Securities Fraud Investigation Into Sionna Therapeutics, Inc. (SION) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz GlobeNewswire
SIONSionna Therapeutics, Inc. Legal Sionna Therapeutics, Inc. (SION) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation GlobeNewswire
SIONSionna Therapeutics, Inc. Legal SION INVESTIGATION ALERT: Investigation Launched into Sionna Therapeutics, Inc., RGRD Law Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm Newsfile Corp
SIONSionna Therapeutics, Inc. Stock news Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead The Motley Fool
See more
FAQ

Questions about Sionna Therapeutics, Inc.

What does Sionna Therapeutics, Inc. do?
Sionna Therapeutics, Inc. is a biopharmaceutical company developing a treatment paradigm for cystic fibrosis patients by creating medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator.
What is SION's market cap?
Sionna Therapeutics, Inc. (SION) is a listed stock with a live quote. The latest market cap on this page is $168M.
Where is Sionna Therapeutics, Inc. headquartered?
Sionna Therapeutics, Inc. is headquartered in Waltham, MA.
How do I get SION news from the API?
Call GET /v1/news?tickers=SION. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does SION news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for SION, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the SION price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs